Group One Trading’s DiaMedica Therapeutics DMAC Stock Holding History

Group One Trading’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.09K	Sell	1,342 -47	-3%	-$372	﹤0.01%	6419
2025 Q4	$11.1K	Buy	1,389 +1,002	+259%	+$7.49K	﹤0.01%	6760
2025 Q3	$2.66K	Buy	387 +266	+220%	+$1.44K	﹤0.01%	7814
2025 Q2	$472	Buy	+121	New	+$472	﹤0.01%	7668
2024 Q1	–	Sell	-4,843	Closed	-$14.1K	–	7221
2023 Q4	$13.8K	Buy	+4,843	New	+$12K	﹤0.01%	5998
2022 Q2	–	Sell	-20	Closed	-$47	–	7953
2022 Q1	$0	Sell	20 -33,848	-100%	-$96K	﹤0.01%	8144
2021 Q4	$126K	Buy	33,868 +9,650	+40%	+$37.9K	﹤0.01%	5512
2021 Q3	$97K	Buy	24,218 +20,496	+551%	+$78.4K	﹤0.01%	5943
2021 Q2	$17K	Buy	+3,722	New	+$30.5K	﹤0.01%	7280

Other funds holding DMAC

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's DMAC Position: Q1 2026 in Review

Group One Trading reduced its DiaMedica Therapeutics (DMAC) stake by 3.4% in Q1 2026, selling an estimated $372 and leaving 1,342 shares worth $9.09K. The position accounts for ﹤0.01% of the portfolio, ranked #6419.

Group One Trading first reported a position in DMAC in Q2 2021 and has held it in 9 quarters since. The position peaked at $126K in Q4 2021. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

Group One Trading held 1,342 shares of DiaMedica Therapeutics worth $9.09K as of Q1 2026.
Group One Trading sold 47 DiaMedica Therapeutics shares in Q1 2026, an estimated $372.
DiaMedica Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6419 holding.
Group One Trading first reported a position in DiaMedica Therapeutics in Q2 2021 and has held it in 9 quarters since.
Group One Trading's DiaMedica Therapeutics position peaked at $126K in Q4 2021.
98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.